During the past decade, Seton Medical Center conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 17 clinical trials were completed, i.e. on average, 70.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 10 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seton Medical Center" #1 sponsor was "Abbott Medical Devices" with 7 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "University of Miami" with 2 trials sponsored, "Alexion" with 1 trials sponsored and "Arkansas Children's Hospital Research Institute" with 1 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seton Medical Center" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator, "Medical University of South Carolina" with 4 trials as a collaborator, "Neurological Emergencies Treatment Trials Network (NETT)" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "American Heart Association" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Seton Medical Center" are "Coronary Artery Disease" (4 trials), "Heart Failure" (4 trials), "Stroke" (4 trials), "Cardiovascular Disease" (2 trials) and "Coronary Artery Stenosis" (2 trials). Many other conditions were trialed in "Seton Medical Center" in a lesser frequency.

Most popular intervention types in "Seton Medical Center" are "Device" (17 trials), "Drug" (13 trials), "Biological" (4 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Absorb BVS" (2 trials), "XIENCE" (2 trials), "AMPLATZER™ PFO Occluder" (1 trials) and "ASA 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seton Medical Center" are 36 trials for "All" genders.

Currently, there are NaN active trials in "Seton Medical Center". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Seton Medical Center, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Seton Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 11 trials that are defined as “Not Applicable".